TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MAYNE PHARMA

DermatologyImmunologyGastroenterology
Specialty

MAYNE PHARMA is a specialty pharmaceutical company focused on Dermatology, Immunology, Gastroenterology. Key products include TOLSURA.

1985
Since
20
Drugs
-
Trials
17
Approved (2yr)

Key Drugs

TOLSURA
itraconazole
4 indications · 2018
RHOFADE
oxymetazoline hydrochloride
alpha 1A adrenoceptor 2 indications · 2017
IMVEXXY
estradiol
Estrogen Receptor 2 indications · 2018
FABIOR
tazarotene
RARα 1 indications · 2012
EPSOLAY
benzoyl peroxide
1 indications · 2022

Recent Activity

BIJUVA 2026-02-12
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-100 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-75 2025-12-22
Labeling
FENTANYL-100 2025-12-22
Labeling
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-04-09
Labeling
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-03-31
Labeling
DORYX MPC 2025-03-31
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 60%
2 drugs
Immunology 35%
1 drugs Phase 1: 1
Gastroenterology 5%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Dermatology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Gastroenterology
MALLINCKRODT specialty
Gastroenterology, Dermatology, Immunology
VALEANT PHARM INTL big-pharma
Dermatology, Immunology, Gastroenterology
COREPHARMA other
Immunology, Gastroenterology, Dermatology